Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBIT: 2010-2025

Historic EBIT for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $1.9 million.

  • Cryo Cell International's EBIT rose 3674.0% to $1.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $4.3 million, marking a year-over-year increase of 13441.23%. This contributed to the annual value of $3.5 million for FY2024, which is 12828.57% up from last year.
  • Per Cryo Cell International's latest filing, its EBIT stood at $1.9 million for Q3 2025, which was up 3674.0% from $1.5 million recorded in Q2 2025.
  • Cryo Cell International's 5-year EBIT high stood at $2.0 million for Q2 2021, and its period low was -$16.2 million during Q4 2023.
  • For the 5-year period, Cryo Cell International's EBIT averaged around $193059.6, with its median value being $1.2 million (2022).
  • As far as peak fluctuations go, Cryo Cell International's EBIT soared by 15014.14% in 2022, and later crashed by 409056.27% in 2023.
  • Cryo Cell International's EBIT (Quarter) stood at -$808434.0 in 2021, then skyrocketed by 150.14% to $405360.0 in 2022, then plummeted by 4090.56% to -$16.2 million in 2023, then soared by 99.24% to -$122347.0 in 2024, then surged by 1653.4% to $1.9 million in 2025.
  • Its EBIT stands at $1.9 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.1 million for Q1 2025.